Immunological and Virucidal effect of Amrita Tablet for Prevention of HIV AIDS
Phase 1
- Conditions
- Health Condition 1: R760- Raised antibody titer
- Registration Number
- CTRI/2024/01/062079
- Lead Sponsor
- Satyananda yoga and Ayurveda Research institute Motihari
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients diagnosis to be HIV Positive
Exclusion Criteria
Taking immunomodulatory
drugs
Patient of antiretroviral Therapy
Pregnancy or lactation
Children
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method